These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7703672)

  • 21. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors.
    Cayla C; Labuz D; Machelska H; Bader M; Schäfer M; Stein C
    Anesthesiology; 2012 Feb; 116(2):448-57. PubMed ID: 22273860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants.
    Lerner UH
    Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):481-93. PubMed ID: 7528372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocation of the neutrophil kinin moiety and changes in the regulation of kinin receptors in inflammation.
    Bhoola KD
    Immunopharmacology; 1996 Jun; 33(1-3):247-56. PubMed ID: 8856158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the kallikrein-kinin system in joint inflammatory disease.
    Sharma JN
    Pharmacol Res; 1991 Feb; 23(2):105-12. PubMed ID: 1648214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases.
    Schremmer-Danninger E; Naidoo S; Neuhof C; Valeske K; Snyman C; Sander C; Bhoola KD; Neuhof H
    Biol Chem; 2004 Nov; 385(11):1069-76. PubMed ID: 15576327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor.
    Kryza T; Lalmanach G; Lavergne M; Lecaille F; Reverdiau P; Courty Y; Heuzé-Vourc'h N
    Biol Chem; 2013 Mar; 394(3):385-91. PubMed ID: 23152405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kallikrein and kinin receptor expression in inflammation and cancer.
    Bhoola K; Ramsaroop R; Plendl J; Cassim B; Dlamini Z; Naicker S
    Biol Chem; 2001 Jan; 382(1):77-89. PubMed ID: 11258677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
    Brechter AB; Lerner UH
    Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.
    Leeb-Lundberg LM; Marceau F; Müller-Esterl W; Pettibone DJ; Zuraw BL
    Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradykinin antagonists: development and applications.
    Stewart JM
    Biopolymers; 1995; 37(2):143-55. PubMed ID: 7893946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.
    Schini VB; Boulanger C; Regoli D; Vanhoutte PM
    J Pharmacol Exp Ther; 1990 Feb; 252(2):581-5. PubMed ID: 2156053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The response of the airways in asthmatic patients to kinin inhalations define a type-B2 receptor profile].
    Polosa R; Cacciola RR; Holgate ST
    Ann Ital Med Int; 1992; 7(4):220-5. PubMed ID: 1338489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    Drapeau G; Audet R; Levesque L; Godin D; Marceau F
    J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinin B1 receptors as a therapeutic target for inflammation.
    Qadri F; Bader M
    Expert Opin Ther Targets; 2018 Jan; 22(1):31-44. PubMed ID: 29168929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinins--characteristics and role in the circulatory system].
    Gabrylewicz B; Tendera M
    Pol Merkur Lekarski; 2004 Dec; 17(102):547-9. PubMed ID: 15771118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.
    Tschöpe C; Westermann D
    Biol Chem; 2008 Jun; 389(6):707-11. PubMed ID: 18627288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo.
    Viel TA; Buck HS
    Curr Alzheimer Res; 2011 Feb; 8(1):59-66. PubMed ID: 21143155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.